All Stories

  1. Enlarging the phenotypical spectrum of DYNC1H1-related epilepsy
  2. Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy
  3. Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study
  4. Health conditions and social problems in children and adolescents with epilepsy: The role of quality of life by employing the PedsQL-EM
  5. Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology
  6. Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial
  7. Changes in Gray Matter Morphology and White Matter Microstructure Across the Adult Lifespan in People With Temporal Lobe Epilepsy
  8. Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study
  9. Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study
  10. Neuroimaging Features of GRIN-Related Epilepsies
  11. Neuroglial biomarkers in autoimmune encephalitis: advances in diagnosis, prognosis, and pathophysiological insights
  12. Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients
  13. Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis
  14. Rasmussen encephalitis and localized scleroderma of the lower limb: Another piece of the puzzle. A case-report and literature review with individual participant data
  15. Dynamic electro‐clinical features in Guanidinoacetate N‐methyltransferase deficiency: A familial case series
  16. Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study
  17. A Novel Epilepsy Phenotype in a Young Girl With a Pathogenic SETD5 Gene Variant
  18. Cerebral Palsy in a Rural Desert Population of Southern Algeria: A Cross-Sectional Study of Epidemiology of Comorbidities and Unmet Needs
  19. EEG microstates during resting-state and dissociative events in patients with psychogenic non-epileptic seizures
  20. Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack
  21. Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study
  22. Self‐Esteem and Psychopathology Differentially Relate to Real‐Life and Social Functioning in People With 22q11.2 Deletion Syndrome
  23. Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study
  24. Medication‐resistant epilepsy is associated with a unique gut microbiota signature
  25. Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
  26. Epileptic spasms and RNA analysis in a new case of Kabuki syndrome type 2
  27. Impact of SDHA Mutations on Yeast Growth and Mitochondrial Function. Case Study Linking Genetic Findings to Clinical Phenotypes
  28. Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort
  29. EEG Abnormalities and Phenotypic Correlates in Preschoolers with Autism Spectrum Disorder: A Single-Center Study
  30. Reconstructing whole-brain structure and dynamics using imaging data and personalized modeling
  31. Cortical Deafness in Children: Scoping Review and Case Report of a Bilateral Perinatal Stroke
  32. Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients
  33. Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case–control study
  34. Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis
  35. Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study
  36. Exploring the Clinical Spectrum of HUWE1 ‐Related Neurodevelopmental Disorder: Five New Patients and Literature Review
  37. Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack
  38. Author Response: Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication
  39. Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis
  40. Diagnosis and Classification of Pediatric Epilepsy in Sub-Saharan Africa: A Comprehensive Review
  41. Combined generalized and focal epilepsy with reflex features in Adaptor protein complex 4-associated hereditary spastic paraplegias: A cohort observational study
  42. Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort
  43. Long‐term outcomes and adaptive behavior in adult patients with Lennox–Gastaut syndrome
  44. Double gonosomal mosaicism as an unusual hereditary mechanism in familial GRIN2A-related disorder
  45. Clinical features and genotype–phenotype correlations in epilepsy patients with de novo DYNC1H1 variants
  46. Epilepsy phenotypes across the different age-ranges in IQSEC2-related encephalopathy: An Italian multicentre retrospective cohort study
  47. Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
  48. Children and Young Adults with Epilepsy Exhibit an Interictal Autonomic Dysfunction: A Prospective Exploratory Study
  49. Depressive symptoms in children and adolescents with epilepsy and primary headache: a cross-sectional observational study
  50. Non-Specific Epileptic Activity, EEG, and Brain Imaging in Loss of Function Variants in SATB1: A New Case Report and Review of the Literature
  51. Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome
  52. Frailty as a comprehensive health measure beyond seizure control in patients with epilepsy: A cross‐sectional study
  53. Structural brain abnormalities in Pallister-Killian syndrome: a neuroimaging study of 31 children
  54. A worldwide ENIGMA study on epilepsy-related gray and white matter compromise across the adult lifespan
  55. Children with Autism Spectrum Disorder and Abnormalities of Clinical EEG: A Qualitative Review
  56. Midline non-ictal rhythmic waveforms as possible electroencephalographic biomarkers of Smith-Klingsmore syndrome in children
  57. A Novel KCNQ2 Variant in a Patient with a Combined Tremor Syndrome
  58. Resting-state electroencephalography microstates as a marker of photosensitivity in juvenile myoclonic epilepsy
  59. Correction to: Resting-state electroencephalography microstates as a marker of photosensitivity in juvenile myoclonic epilepsy
  60. Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study
  61. Correction to “Perampanel as precision therapy in rare genetic epilepsies”
  62. Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy
  63. Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants
  64. The photoparoxysmal response belongs to the spectrum of electroencephalographic findings in patients with triple X syndrome and epilepsy
  65. Models of care in emergency neurology: from the Neuro Fast Track to the emergency neurologist—a position paper of the Italian Association for Emergency Neurology (ANEU)
  66. Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke
  67. Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy
  68. Glycaemic Imbalances in Seizures and Epilepsy of Paediatric Age: A Literature Review
  69. The Central Noradrenergic System in Neurodevelopmental Disorders: Merging Experimental and Clinical Evidence
  70. Perampanel as precision therapy in rare genetic epilepsies
  71. Editorial: Advances in neuroimaging of epilepsy
  72. CUL4B-associated epilepsy: Report of a novel truncating variant promoting drug-resistant seizures and systematic review of the literature.
  73. Does 7T MRI reveal a neuronal bridge between periventricular heterotopia and overlying cortical malformations?
  74. An Italian consensus on the management of Lennox-Gastaut syndrome
  75. Tremor and Movement Slowness Are Two Unrelated Adverse Effects Induced by Valproate Intake
  76. Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients
  77. Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study
  78. Different epilepsy course of a novel AHDC1 mutation in a female monozygotic twin pair
  79. Drug-resistant epilepsy at the age extremes: Disentangling the underlying etiology
  80. The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
  81. Event‐based modelling in temporal lobe epilepsy demonstrates progressive atrophy
  82. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)
  83. Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
  84. Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
  85. Hyperosmolar hyperglycaemic state causing atypical status epilepticus with hippocampal involvement
  86. Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy
  87. Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
  88. Inherited Developmental and Epileptic Encephalopathies
  89. Drugs for patients with epilepsy and excessive daytime sleepiness
  90. Neurological disorders associated with COVID-19 infection: An Italian multi-center cohort study (NEURO-COVID)
  91. Progressive supranuclear palsy: Clinical, instrumental and neuropsychological evaluation of a case in the presymptomatic phase
  92. Trigeminal neuralgia post COVID-19: Preliminary report and clinical consideration
  93. A systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies
  94. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
  95. Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence
  96. Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice
  97. Letter to the editor: focal non-convulsive status epilepticus manifesting as utilization behavior
  98. Climate change and epilepsy: Insights from clinical and basic science studies
  99. Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy
  100. Brivaracetam as add‐on treatment in focal epilepsy: A real‐world time‐based analysis
  101. Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study
  102. White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study
  103. The ENIGMA‐Epilepsy working group: Mapping disease from large data sets
  104. Network-based atrophy modelling in the common epilepsies: a worldwide ENIGMA study
  105. Pediatric medical psychology
  106. White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA Epilepsy study
  107. Epilepsy and brain channelopathies from infancy to adulthood
  108. Ultra-High-Field Targeted Imaging of Focal Cortical Dysplasia: The Intracortical Black Line Sign in Type IIb
  109. Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy
  110. Transcranial color‐coded sonography may indirectly reveal an intracranial meningioma
  111. Acute-Onset Vertical Nystagmus and Limb Tremors in Chronic Renal Failure
  112. Italian census on neurosciences: the ICoNe2 study
  113. A systems-level analysis highlights microglial activation as a modifying factor in common forms of human epilepsy
  114. Limb Shaking Transient Ischemic Attacks with Normal Neurovascular Ultrasound may Herald Cardioembolic Stroke: A Case Report
  115. The application of artificial intelligence to understand the pathophysiological basis of psychogenic nonepileptic seizures
  116. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI)
  117. Left inferior frontal cortex can compensate the inhibitory functions of right inferior frontal cortex and pre-supplementary motor area
  118. Central Precocious Puberty in a Child With Metachromatic Leukodystrophy
  119. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
  120. Hemicerebellitis can drive handedness shift
  121. Alexithymic trait is associated with right IFG and pre-SMA activation in non-emotional response inhibition in healthy subjects
  122. Erratum to Diffuse Brain Hypoperfusion in Advanced Leukoencephalopathy with Calcifications and Cysts
  123. Fast Progression of Cerebellar Atrophy in PLA2G6-Associated Infantile Neuronal Axonal Dystrophy
  124. Isolated recurrent myelitis in a 7-year-old child with serum aquaporin-4 IgG antibodies
  125. Immune Response to Invasive Group BStreptococcusDisease in Adults
  126. Teaching Neuro Images : Spinal cord gray matter involvement in complex I deficiency mitochondriopathy
  127. Effectiveness of 3D T2-Weighted FLAIR FSE Sequences with Fat Suppression for Detection of Brain MR Imaging Signal Changes in Children
  128. Diffuse Brain Hypoperfusion in Advanced Leukoencephalopathy with Calcifications and Cysts
  129. The syndrome of polymicrogyria, thalamic hypoplasia, and epilepsy with CSWS
  130. 7T MRI in focal epilepsy with unrevealing conventional field strength imaging
  131. Central precocious puberty due to hypothalamic hamartoma in neurofibromatosis type 1
  132. Central precocious puberty due to hypothalamic hamartoma in neurofibromatosis type 1
  133. Abnormal response to photic stimulation in Juvenile Myoclonic Epilepsy: An EEG-fMRI study
  134. Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation
  135. Atypical face shape and genomic structural variants in epilepsy
  136. Posterior reversible encephalopathy syndrome in a complicated autoimmune background: differential diagnosis and etiological hypothesis
  137. Validation of the Italian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)
  138. Incidence and management of late postsurgical seizures in clinical practice.
  139. The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre
  140. Multicultural challenges in epilepsy
  141. Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome
  142. Health-related quality of life in epilepsy: Findings obtained with a new Italian instrument
  143. Incidence, risk factors and short-term mortality of stroke in Vittoria, southern Italy
  144. Oxidative stress signalling in the apoptosis of Jurkat T‐lymphocytes
  145. 424 III – VI – VII cranial nerve disorders in a patient suffering from hemorrhage in brainstem: Blink reflex and BAEP's study
  146. Regulation of the Human <i>glut4</i> Gene Expression in Tumor RD18 Cell Line